Clinical Trial Update: Multicenter Study Assessing the Efficacy and Safety of DE-126 Ophthalmic Solution 0.002% Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 multicenter trial comparing DE-126 ophthalmic solution to timolol in primary open-angle glaucoma or ocular hypertension has completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• DE-126 ophthalmic solution 0.002% (DE-126)
• Timolol ophthalmic solution 0.5% (Timolol)

Snippet

Sponsor: Santen Inc. | Conditions: Primary Open Angle Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2023-01-26